Joel Isaacson & Co’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $951K | Hold |
2,458
| – | – | 0.03% | 207 |
|
|
2026
Q1 | $720K | Sell |
2,458
-103
| -4% | -$33.9K | 0.02% | 231 |
|
|
2025
Q4 | $898K | Buy |
2,561
+796
| +45% | +$269K | 0.03% | 199 |
|
|
2025
Q3 | $570K | Buy |
1,765
+550
| +45% | +$171K | 0.02% | 250 |
|
|
2025
Q2 | $473K | Hold |
1,215
| – | – | 0.02% | 263 |
|
|
2025
Q1 | $528K | Sell |
1,215
-28
| -2% | -$11.2K | 0.02% | 234 |
|
|
2024
Q4 | $459K | Hold |
1,243
| – | – | 0.02% | 239 |
|
|
2024
Q3 | $646K | Buy |
1,243
+103
| +9% | +$55K | 0.03% | 185 |
|
|
2024
Q2 | $618K | Sell |
1,140
-105
| -8% | -$55.5K | 0.03% | 188 |
|
|
2024
Q1 | $646K | Hold |
1,245
| – | – | 0.04% | 181 |
|
|
2023
Q4 | $587K | Sell |
1,245
-110
| -8% | -$50.9K | 0.04% | 173 |
|
|
2023
Q3 | $590K | Hold |
1,355
| – | – | 0.04% | 168 |
|
|
2023
Q2 | $602K | Buy |
1,355
+715
| +112% | +$330K | 0.04% | 167 |
|
|
2023
Q1 | $294K | Hold |
640
| – | – | 0.02% | 261 |
|
|
2022
Q4 | $328K | Hold |
640
| – | – | 0.03% | 227 |
|
|
2022
Q3 | $291K | Sell |
640
-6
| -0.9% | -$2.87K | 0.03% | 234 |
|
|
2022
Q2 | $312K | Buy |
646
+19
| +3% | +$9.4K | 0.03% | 228 |
|
|
2022
Q1 | $322K | Hold |
627
| – | – | 0.02% | 243 |
|
|
2021
Q4 | $291K | Hold |
627
| – | – | 0.02% | 258 |
|
|
2021
Q3 | $234K | Buy |
627
+6
| +1% | +$2.28K | 0.02% | 282 |
|
|
2021
Q2 | $237K | Hold |
621
| – | – | 0.02% | 263 |
|
|
2021
Q1 | $223K | Buy |
+621
| New | +$200K | 0.02% | 241 |
|
|
2017
Q1 | – | Sell |
-559
| Closed | -$80K | – | 281 |
|
|
2016
Q4 | $80K | Hold |
559
| – | – | 0.02% | 247 |
|
|
2016
Q3 | $70K | Hold |
559
| – | – | 0.01% | 277 |
|
|
2016
Q2 | $73K | Sell |
559
-2,000
| -78% | -$274K | 0.02% | 272 |
|
|
2016
Q1 | $356K | Hold |
2,559
| – | – | 0.08% | 122 |
|
|
2015
Q4 | $357K | Sell |
2,559
-16
| -0.6% | -$2.2K | 0.09% | 105 |
|
|
2015
Q3 | $361K | Sell |
2,575
-92
| -3% | -$13.8K | 0.1% | 95 |
|
|
2015
Q2 | $438K | Buy |
2,667
+127
| +5% | +$20.3K | 0.11% | 92 |
|
|
2015
Q1 | $392K | Buy |
2,540
+212
| +9% | +$30.2K | 0.1% | 102 |
|
|
2014
Q4 | $293K | Hold |
2,328
| – | – | 0.08% | 115 |
|
|
2014
Q3 | $278K | Buy |
2,328
+16
| +0.7% | +$1.83K | 0.09% | 99 |
|
|
2014
Q2 | $249K | Hold |
2,312
| – | – | 0.08% | 106 |
|
|
2014
Q1 | $230K | Hold |
2,312
| – | – | 0.08% | 107 |
|
|
2013
Q4 | $214K | Hold |
2,312
| – | – | 0.08% | 105 |
|
|
2013
Q3 | $193K | Hold |
2,312
| – | – | 0.08% | 108 |
|
|
2013
Q2 | $189K | Buy |
+2,312
| New | +$173K | 0.09% | 97 |
|
Other funds holding ELV
AACR
Joel Isaacson & Co's ELV Position: Q2 2026 in Review
Joel Isaacson & Co held its Elevance Health (ELV) position steady in Q2 2026 at 2,458 shares worth $951K. The position accounts for 0.03% of the portfolio, ranked #207.
Joel Isaacson & Co first reported a position in ELV in Q2 2013 and has held it in 37 quarters since. 917 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Joel Isaacson & Co held 2,458 shares of Elevance Health worth $951K as of Q2 2026.
- Joel Isaacson & Co left its Elevance Health share count unchanged in Q2 2026.
- Elevance Health made up 0.03% of Joel Isaacson & Co's portfolio in Q2 2026, its #207 holding.
- Joel Isaacson & Co first reported a position in Elevance Health in Q2 2013 and has held it in 37 quarters since.
- 917 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Joel Isaacson & Co's 13F filing for Q2 2026, filed 4 Aug 2026.